Company: JUNS
Filing Date: 2025-04-21
Form Type: 8-K
Source: 0001641172-25-005506
Chunk: 0

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-04-21
Form: 8-K
Item: Item 4.01
Chunk 0
---
Item       Changes                                 

Assurance
Dimensions, LLC (“ AD”), the independent registered public accounting firm for Jupiter Neurosciences, Inc. advised the Company
that it was resigning as the independent registered accounting for the Company, effective as of April 16, 2025, as a result of its decision
to discontinue its PCAOB registrants practice. Concurrent with such resignation, the Audit Committee of the Board of Directors of the
Company approved the engagement of Cherry Bekaert LLP (“ CB”) as the new independent registered public accounting firm
for the Company, effective as of April 16, 2025.

The
audit reports of AD on the Company’s financial statements for the years ended December 31, 2024 and 2023 did not contain an adverse
opinion or a disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles, except
that AD’s report on the Company’s consolidated financial statements as of and for the years ended December 31, 2024 and 2023,
disclosed uncertainty regarding the Company’s ability to continue as a going concern.

During
the two most recent fiscal years ended December 31, 2024 and 2023 and the subsequent interim period through the date of AD’s resignation,
there were no: (i) disagreements between the Company and AD on any matter of accounting principles or practices, financial statement
disclosure, or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of AD would have caused them to
make reference thereto in their reports on the Company’s financial statements for such years or (ii) reportable events, as defined
in Item 304(a)(1)(v) of Regulation S-K.

During
the two most recent fiscal years ended December 31, 2024 and 2023 and the subsequent interim period through the date of CB’s engagement,
the Company did not consult with CB on either (1) the application of accounting principles to a specified transaction, either completed
or proposed; or the type of audit opinion that may be rendered on the Company’s financial statements, and CB did not provide either
a written report or oral advice to the Company that CB concluded was an important factor considered by the Company in reaching a decision
as to the accounting, auditing or financial reporting issue; or (2) any matter that was either the subject of a disagreement, as defined
in Item 304(a)(1)(iv) of Regulation S-K and the